{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T03:47:21Z","timestamp":1776570441036,"version":"3.51.2"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","oooojournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.oooo.2025.11.009","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T07:52:12Z","timestamp":1764316332000},"page":"762-771","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment protocol for medication-related osteonecrosis of the jaws: stages I and II-based on a pharmacological and surgical scheme"],"prefix":"10.1016","volume":"141","author":[{"given":"Nicol\u00e1s","family":"Leonardi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5201-1444","authenticated-orcid":false,"given":"Gerardo","family":"Gilligan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo David","family":"Piemonte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rene Luis","family":"Panico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.oooo.2025.11.009_bib0001","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"issue":"5","key":"10.1016\/j.oooo.2025.11.009_bib0002","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"issue":"10","key":"10.1016\/j.oooo.2025.11.009_bib0003","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"issue":"2","key":"10.1016\/j.oooo.2025.11.009_bib0004","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.job.2019.03.005","article-title":"Medication-related osteonecrosis of the jaw: a literature review","volume":"61","author":"Kuroshima","year":"2019","journal-title":"J Oral Biosci"},{"key":"10.1016\/j.oooo.2025.11.009_bib0005","series-title":"Antiresorptive drug-related osteonecrosis of the jaw (ARONJ): a guide to research","author":"Fleisher","year":"2016"},{"issue":"9","key":"10.1016\/j.oooo.2025.11.009_bib0006","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.bjoms.2014.07.256","article-title":"Leucocyte-rich and platelet-rich fibrin for the treatment of bisphosphonate-related osteonecrosis of the jaw: a prospective feasibility study","volume":"52","author":"Kim","year":"2014","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"10","key":"10.1016\/j.oooo.2025.11.009_bib0007","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD012432.pub2","article-title":"Interventions for managing medication-related osteonecrosis of the jaw. Cochrane Oral Health Group, ed","author":"Beth-Tasdogan","year":"2017","journal-title":"Cochrane Database Systemat Rev"},{"issue":"8","key":"10.1016\/j.oooo.2025.11.009_bib0008","first-page":"e1051","article-title":"The role of leucocyte-rich and platelet-rich fibrin (L-PRF) in the treatment of the medication-related osteonecrosis of the jaws (MRONJ)","volume":"9","author":"Cano-Duran","year":"2017","journal-title":"J Clin Exp Dent"},{"key":"10.1016\/j.oooo.2025.11.009_bib0009","article-title":"Interventions for managing medication-related osteonecrosis of the jaw. Cochrane Oral Health Group, ed","volume":"2022","author":"Beth-Tasdogan","year":"2022"},{"issue":"1","key":"10.1016\/j.oooo.2025.11.009_bib0010","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/jop.13083","article-title":"Weak evidence for the management of medication-related osteonecrosis of the jaw: an overview of systematic reviews and meta-analyses","volume":"50","author":"Moraschini","year":"2021","journal-title":"J Oral Pathol Med"},{"issue":"11","key":"10.1016\/j.oooo.2025.11.009_bib0011","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jcms.2020.09.008","article-title":"Pentoxifylline and tocopherol protocol to treat medication-related osteonecrosis of the jaw: a systematic literature review","volume":"48","author":"Cavalcante","year":"2020","journal-title":"J Cranio-Maxillofac Surg"},{"issue":"4","key":"10.1016\/j.oooo.2025.11.009_bib0012","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.oooo.2016.06.019","article-title":"Pentoxifylline and tocopherol in the management of cancer patients with medication-related osteonecrosis of the jaw: an observational retrospective study of initial case series","volume":"122","author":"Owosho","year":"2016","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"2","key":"10.1016\/j.oooo.2025.11.009_bib0013","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jcms.2014.11.014","article-title":"Treatment perspectives for medication-related osteonecrosis of the jaw (MRONJ)","volume":"43","author":"Ristow","year":"2015","journal-title":"J Cranio-Maxillofac Surg"},{"issue":"5","key":"10.1016\/j.oooo.2025.11.009_bib0014","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.tripleo.2010.05.067","article-title":"Management of bisphosphonate-associated osteonecrosis: pentoxifylline and tocopherol in addition to antimicrobial therapy. An initial case series","volume":"110","author":"Epstein","year":"2010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol"},{"issue":"2","key":"10.1016\/j.oooo.2025.11.009_bib0015","doi-asserted-by":"crossref","first-page":"318","DOI":"10.31053\/1853.0605.v82.n2.46061","article-title":"Drug-related jaw osteonecrosis: a 6-year retrospective study from two centers in Argentina","volume":"82","author":"Leonardi","year":"2025","journal-title":"Rev Fac Cien Med Univ Nac Cordoba"},{"issue":"5","key":"10.1016\/j.oooo.2025.11.009_bib0016","doi-asserted-by":"crossref","first-page":"739","DOI":"10.20945\/2359-3997000000563","article-title":"Male osteoporosis","volume":"66","author":"Bandeira","year":"2022","journal-title":"Arch Endocrinol Metabol"},{"issue":"5","key":"10.1016\/j.oooo.2025.11.009_bib0017","doi-asserted-by":"crossref","first-page":"259","DOI":"10.12968\/hmed.2018.79.5.259","article-title":"Treatment of osteoporosis: whom, how and for how long?","volume":"79","author":"Dede","year":"2018","journal-title":"Br J Hosp Med"},{"issue":"11","key":"10.1016\/j.oooo.2025.11.009_bib0018","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.jfma.2021.01.015","article-title":"The status of jaw lesions and medication-related osteonecrosis of jaw in patients with multiple myeloma","volume":"120","author":"Lu","year":"2021","journal-title":"J Formos Med Assoc"},{"issue":"2","key":"10.1016\/j.oooo.2025.11.009_bib0019","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.joms.2013.06.188","article-title":"Pentoxifylline and tocopherol in the treatment of yearly zoledronic acid\u2013related osteonecrosis of the jaw in a corticosteroid-induced osteoporosis","volume":"72","author":"Magremanne","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"issue":"1","key":"10.1016\/j.oooo.2025.11.009_bib0020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41413-020-00105-1","article-title":"Molecular mechanisms and clinical management of cancer bone metastasis","volume":"8","author":"Wang","year":"2020","journal-title":"Bone Res"},{"issue":"5","key":"10.1016\/j.oooo.2025.11.009_bib0021","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.oooo.2019.08.004","article-title":"Systematic review of the use of pentoxifylline and tocopherol for the treatment of medication-related osteonecrosis of the jaw","volume":"128","author":"Heifetz-Li","year":"2019","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"2","key":"10.1016\/j.oooo.2025.11.009_bib0022","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.joms.2013.06.188","article-title":"Pentoxifylline and tocopherol in the treatment of yearly zoledronic acid\u2013related osteonecrosis of the jaw in a corticosteroid-induced osteoporosis","volume":"72","author":"Magremanne","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"issue":"10","key":"10.1016\/j.oooo.2025.11.009_bib0023","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 Update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"issue":"3","key":"10.1016\/j.oooo.2025.11.009_bib0024","doi-asserted-by":"crossref","DOI":"10.4321\/S1130-05582008000300001","article-title":"Diagn\u00f3stico, prevenci\u00f3n y tratamiento de la osteonecrosis de los maxilares por bisfosfonatos: Recomendaciones de la Sociedad Espa\u00f1ola de Cirug\u00eda Oral y Maxilofacial (SECOM)","volume":"30","author":"Junquera","year":"2008","journal-title":"Rev Esp Cirug Oral y Maxilofac"},{"issue":"2","key":"10.1016\/j.oooo.2025.11.009_bib0025","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jcms.2014.11.014","article-title":"Treatment perspectives for medication-related osteonecrosis of the jaw (MRONJ)","volume":"43","author":"Ristow","year":"2015","journal-title":"J Cranio-Maxillofac Surg"},{"issue":"2","key":"10.1016\/j.oooo.2025.11.009_bib0026","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00784-013-0979-2","article-title":"Relevance of surgical management of patients affected by bisphosphonate-associated osteonecrosis of the jaws. A prospective clinical and radiological study","volume":"18","author":"Lesclous","year":"2014","journal-title":"Clin Oral Invest"},{"issue":"6","key":"10.1016\/j.oooo.2025.11.009_bib0027","doi-asserted-by":"crossref","first-page":"e787","DOI":"10.4317\/medoral.27249","article-title":"Efficacy of leukocyte- and platelet-rich fibrin in the treatment and prevention of medication-related osteonecrosis of the jaw: a prospective study","volume":"30","author":"Medeiros-Monz\u00f3n","year":"2025","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10.1016\/j.oooo.2025.11.009_bib0028","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.freeradbiomed.2014.03.035","article-title":"Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy","volume":"72","author":"Jiang","year":"2014","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"10.1016\/j.oooo.2025.11.009_bib0029","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.tripleo.2010.05.067","article-title":"Management of bisphosphonate-associated osteonecrosis: pentoxifylline and tocopherol in addition to antimicrobial therapy. An initial case series","volume":"110","author":"Epstein","year":"2010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol"},{"issue":"12 Suppl 2","key":"10.1016\/j.oooo.2025.11.009_bib0030","article-title":"Is the use of pentoxifylline and tocopherol effective in the treatment of osteoradionecrosis of the jaws or for the treatment of medicationosteonecrosis of the jaw? An overview","volume":"125","author":"de Morais","year":"2024","journal-title":"J Stomatol Oral Maxillofac Surg"}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440325013227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440325013227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T03:31:27Z","timestamp":1776569487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212440325013227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2212440325013227"],"URL":"https:\/\/doi.org\/10.1016\/j.oooo.2025.11.009","relation":{},"ISSN":["2212-4403"],"issn-type":[{"value":"2212-4403","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment protocol for medication-related osteonecrosis of the jaws: stages I and II-based on a pharmacological and surgical scheme","name":"articletitle","label":"Article Title"},{"value":"Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oooo.2025.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}